Table 1.

Summary of the sequence assembly for each treatment group.

Samples	Total reads	Total nucleotides (bp)	GC%	Q30%
Control-1	22,498,116	3,374,717,400	52.59	95.34
Control-2	28,105,672	4,215,850,800	52.68	95.38
F5D1-1	23,992,856	3,598,928,400	52.85	95.4
F5D1-2	31,759,734	4,763,960,100	53	95.34
F5D3-1	25,744,530	3,861,679,500	52.23	95.3
F5D3-2	27,129,926	4,069,488,900	52.37	95.36
F20D1-1	25,418,168	3,812,725,200	52.65	95.33
F20D1-2	31,876,778	4,781,516,700	53.36	95.34
F20D3-1	26,754,336	4,013,150,400	52.75	95.25
F20D3-2	27,129,926	4,093,988,400	52.86	95.3
Average	27,041,004	4,058,600,580	53	95

Control: sample collected before F treatment; F5D1: 5 mg/L F for 1 day; F5D3: 5 mg/L F for 3 days; F20D1: 20 mg/L F for 1 day; F20D3: 20 mg/L F for 3 days; 1 and 2 for biological replicates.